Treating Pediatric Cancers

Here is a link to an article about the surprising success of using Crizotinib to treat three pediatric cancers (anaplastic large cell lymphoma(ALCL), inflammatory myofibroblastic tumors, and neuroblastomas).

For example, 88% of the treated ALCL Patients experienced a complete response with no detectable disease.

http://www.healio.com/hematology-oncology/highlights-from-asco-2012/alk-inhibitor-induced-strong-response-in-three-types-of-pediatric-cancers

This entry was posted in Anaplastic Large-Cell Lymphomas, Neuroblastomas, Potential Treatments. Bookmark the permalink.

Leave a Reply